{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:56:36Z","timestamp":1791464196761,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.brainresbull.2012.10.006","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T03:03:43Z","timestamp":1351307023000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca2+ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER)"],"prefix":"10.1016","volume":"90","author":[{"given":"Hai-Dun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumatoshi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Hanaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Kurisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Serikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2012.10.006_bib0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1528-1157.2001.11300.x","article-title":"Enhanced calcium influx in hippocampal CA3 neurons of spontaneously epileptic rats","volume":"42","author":"Amano","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0006-8993(01)02700-7","article-title":"Enhanced Ca2+ influx with mossy fiber stimulation in hippocampal CA3 neurons of spontaneously epileptic rats","volume":"910","author":"Amano","year":"2001","journal-title":"Brain Research"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/PL00005097","article-title":"Levetiracetam (ucb L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission","volume":"356","author":"Birnstiel","year":"1997","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmcology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0020","first-page":"1362","article-title":"Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiractam from conventional antiepileptic drugs","volume":"26","author":"Cai","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(95)00077-1","article-title":"Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy","volume":"22","author":"Gower","year":"1995","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)90855-X","article-title":"ucb L059, a novel anti-convulsant drug: pharmacological profile in animals","volume":"222","author":"Gower","year":"1992","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-8993(98)00116-4","article-title":"Suppression by topiramate of epleptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro","volume":"789","author":"Hanaya","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.brainresbull.2011.09.015","article-title":"Modulation of abnormal synaptic transmission ifn hippocampal CA3 neurons of spontaneously epilepitic rats (SERs) by levetiracetam","volume":"86","author":"Hanaya","year":"2011","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/exnr.1993.1032","article-title":"Abnormal excitability of hippocampal CA3 pyramidal neurons of spontaneously epileptic rats (SER), a double mutant","volume":"119","author":"Ishihara","year":"1993","journal-title":"Experimental Neurology"},{"issue":"July","key":"10.1016\/j.brainresbull.2012.10.006_bib0050","first-page":"E1","article-title":"Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy","volume":"9","author":"Klein","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaad","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90768-D","article-title":"Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats","volume":"232","author":"L\u00f6scher","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"L\u00f6scher","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","article-title":"Selective blockade of N-type calcium channels by levetiracetam","volume":"43","author":"Lukyanetz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0075","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.2000.0689","article-title":"Inhibition of neuronal hyper-synchrony in vitro differentiates levetiracetam from classical antiepileptic drugs","volume":"42","author":"Margineanu","year":"2000","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(95)00189-R","article-title":"Effect of nicardipine on abnormal excitability of CA3 pyramidal cells in hippocampal slices of spontaneously epileptic rats","volume":"280","author":"Momiyama","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurons of rat hippocampal slices","volume":"306","author":"Niespodziany","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00436-O","article-title":"The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes","volume":"286","author":"Noyer","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eplepsyres.2010.01.011","article-title":"Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model","volume":"80","author":"Ohno","year":"2010","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0170","series-title":"The rat brain, in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0105","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.0b013e31826d5ec0","article-title":"Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review","volume":"79","author":"Pellock","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1528-1157.1988.tb03754.x","article-title":"Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat","volume":"29","author":"Sasa","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1528-1157.1990.tb05353.x","article-title":"Long-term effects of continual intake of phenobarbital on the spontaneously epileptic rat","volume":"31","author":"Serikawa","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.jhered.a110277","article-title":"Epileptic seizures in rats homozygous for two mutations, zitter and tremor","volume":"77","author":"Serikawa","year":"1986","journal-title":"The Journal of Heredity"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1528-1157.1997.tb01477.x","article-title":"Voltage-activated calcium channels: targets of antiepileptic drug therapy?","volume":"38","author":"Stefani","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainresbull.2011.05.017","article-title":"Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneopusly epileptic rats","volume":"86","author":"Sugata","year":"2011","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2010.08.084","article-title":"Inhibitory effects of levetiracetam on absence seizures in a novel absence-like epilepsy model, Groggy rat","volume":"1359","author":"Tokuda","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0150","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1528-1167.2005.35204.x","article-title":"Separation of antiepieltptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER)","volume":"46","author":"Yan","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1528-1167.2007.00957.x","article-title":"Voltage-dependent calcium channel abnormalities in hippocampal CA3 neurons of spontaneously epileptic rats","volume":"48","author":"Yan","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0160","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1528-1167.2006.01132.x","article-title":"Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission","volume":"48","author":"Yang","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2012.10.006_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/seiz.2000.0504","article-title":"Levetiracetam dose not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents","volume":"10","author":"Zona","year":"2001","journal-title":"Seizure"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923012002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923012002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:15:39Z","timestamp":1759781739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923012002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":32,"alternative-id":["S0361923012002328"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2012.10.006","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca2+ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER)","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2012.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}